Spots Global Cancer Trial Database for arimidex
Every month we try and update this database with for arimidex cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer | NCT00884143 | Post Menopausal Breast Cancer | - | AstraZeneca | ||
| Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer | NCT00181688 | Ovarian Cancer Peritoneal Carc... Tubal Carcinoma | Iressa (ZD1839) Arimidex (Anast... | 18 Years - | Massachusetts General Hospital | |
| Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence | NCT01081509 | Breast Cancer | - | AstraZeneca | ||
| Breast Cancer Tumor Care Observational Programme | NCT00660244 | Post Menopausal Arthralgia | anastrozole | - | AstraZeneca | |
| Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast | NCT03304080 | Breast Neoplasm... Breast Diseases | Anastrozole Palbociclib Trastuzumab Pertuzumab | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer | NCT00884143 | Post Menopausal Breast Cancer | - | AstraZeneca | ||
| Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors | NCT00738998 | Breast Cancer | Questionnaire Phone Calls | 18 Years - | M.D. Anderson Cancer Center | |
| Arimidex Bone Mass Index and Oral Bisphosphonates | NCT00809484 | Breast Cancer Bone Density | 18 Years - 80 Years | Hellenic Breast Surgeons Society | ||
| The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer | NCT01080170 | Breast Cancer | 60 Years - 75 Years | University of Pittsburgh | ||
| Breast Cancer Tumor Care Observational Programme | NCT00660244 | Post Menopausal Arthralgia | anastrozole | - | AstraZeneca | |
| Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer | NCT01207635 | Breast Cancer | Ductal Lavage F... | - | M.D. Anderson Cancer Center | |
| Longitudinal Assessment of Arthralgia and Related Symptoms in Breast Cancer Patients Receiving Aromatase Inhibitors | NCT00738998 | Breast Cancer | Questionnaire Phone Calls | 18 Years - | M.D. Anderson Cancer Center | |
| Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast | NCT03304080 | Breast Neoplasm... Breast Diseases | Anastrozole Palbociclib Trastuzumab Pertuzumab | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer | NCT00638391 | Breast Cancer | Anastrozole | - | AstraZeneca | |
| Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib | NCT01466972 | Breast Cancer Breast Neoplasm | Pazopanib | 18 Years - | University of California, San Francisco | |
| A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery | NCT05549505 | Breast Cancer | ARV-471 Anastrozole Surgical resect... | 18 Years - | Arvinas Inc. | |
| Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib | NCT01466972 | Breast Cancer Breast Neoplasm | Pazopanib | 18 Years - | University of California, San Francisco | |
| Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast | NCT03304080 | Breast Neoplasm... Breast Diseases | Anastrozole Palbociclib Trastuzumab Pertuzumab | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib | NCT01466972 | Breast Cancer Breast Neoplasm | Pazopanib | 18 Years - | University of California, San Francisco | |
| Anastrozole and Letrozole | NCT00762294 | Breast Cancer | 40 Years - | UConn Health | ||
| Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg | NCT00859560 | Breast Cancer | - | AstraZeneca | ||
| The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer | NCT01080170 | Breast Cancer | 60 Years - 75 Years | University of Pittsburgh | ||
| Arimidex Bone Mass Index and Oral Bisphosphonates | NCT00809484 | Breast Cancer Bone Density | 18 Years - 80 Years | Hellenic Breast Surgeons Society |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
